• Home
  • |
  • Contact us
  • |
  • Chiesi Group Chiesi Group
Chiesi USA incorporated.  People and ideas for innovation in healthcare.
Welcome to Chiesi
United states of America
Enter at least 3 characters
  • About us
    • History
    • Mission & values
    • Our management
    • Compliance
  • Products
  • Research & development
    • Clinical transparency
    • Pipeline
  • News
  • Rare Diseases
    • About Us
    • About Rare Diseases
    • Products
    • Pipeline
    • Partnerships
    • Contacts
  • Sustainability
    • Chiesi in the Community
    • Expanded access programs
    • Sustainability of the Supply Chain
  • Join our team
    • Our culture
    • Our workplace
    • Our people
    • Our pay and benefits
    • Current openings
  • Contact us
    • Patient support
    • Business development
    • Grant program
    • Compliance concerns
    • Medical inquiries
This site uses cookies. Continuing to navigate is considered accepted usage. More info CLOSE
Home page > Sitemap
extra small siz normal size extra large size
print
email

Edit email address
Invalid email
Email Sent
Authorize the processing of personal data
  • Home page
  • About us
    • - History
    • - Mission & values
    • - Our management
    • - Compliance
  • Research & development
    • - Clinical transparency
    • - Pipeline
  • News
  • Rare Diseases
    • - About Us
    • - About Rare Diseases
    • - Products
    • - Pipeline
    • - Partnerships
    • - Contacts
  • Sustainability
    • - Chiesi in the Community
    • - Expanded access programs
    • - Sustainability of the Supply Chain
  • Join our team
    • - Our culture
    • - Our workplace
    • - Our people
    • - Our pay and benefits
    • - Current openings
  • Contact us
    • - Patient support
    • - Business development
    • - Grant program
    • - Compliance concerns
    • - Medical inquiries
  • Products
    • - ARGATROBAN for Injection, 50 mg per 50 mL
    • - BETHKIS® (Tobramycin Inhalation Solution)
    • - CLEVIPREX® (clevidipine) injectable emulsion
    • - CUROSURF® (poractant alfa) Intratracheal Suspension
    • - KENGREAL® (cangrelor) for injection
    • - PERTZYE® (pancrelipase) Delayed-Release Capsules
    • - RETAVASE® (reteplase) for injection
    • - ZYFLO® (zileuton tablets)
  • Contact us
© 2021 CHIESI USA, Inc.
175 Regency Woods Place, Suite 600, Cary, NC 27518
PP-MULTI-0024 V15.0
  • Sitemap
  • Privacy policy
  • Accessibility
  • Terms of use
  • Credits
CHIESI ON THE WEB
chiesi-web
CHIESI USA, Inc.
follow us on:

Linkedin CHIESI USA Inc.
close the box button
CHIESI ON THE WEB
Austria
Chiesi Pharmaceuticals GmbH
Belgium
Chiesi sa
Brazil
Chiesi Farmacêutica Ltda
Bulgaria
Chiesi Bulgaria Ltd.
China
Chiesi Pharmaceutical (Shanghai) Co., Ltd
Czech Republic
Chiesi CZ s.r.o.
France
Chiesi S.A.
Germany
Chiesi GmbH
Greece
Chiesi Hellas Pharmaceuticals S.A.
Hungary
Chiesi Hungary Kft.
Italy
Divisione Farmaceutica Italia
Mexico
Chiesi Mexico S.A. de C.V.
Pakistan
Chiesi Pharmaceuticals (Pvt) Limited
Poland
Chiesi Polonia
Romania
Chiesi România S.r.l.
Russian Federetion
Chiesi Pharmaceuticals LLC
Slovak Republic
Chiesi Slovakia s.r.o
Slovenia
Chiesi Slovenija, d.o.o
Spain
Chiesi España S.A.
Sweden
Chiesi Pharma AB
The Netherlands
Chiesi Pharmaceuticals B.V.
Turkey
Chiesi İlaçTicaret Limited Sirketi  A.Ş.
United Kingdom
Chiesi Ltd
United States
Chiesi Usa Inc.